We are live on ! Find out more

1,410 hedge funds and large institutions have $39.3B invested in MetLife in 2025 Q2 according to their latest regulatory filings, with 126 funds opening new positions, 562 increasing their positions, 504 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 106

12% more repeat investments, than reductions

Existing positions increased: 562 | Existing positions reduced: 504

0% more funds holding

Funds holding: 1,4071,410 (+3)

0.02% less ownership

Funds ownership: 72.89%72.87% (-0.02%)

1% less capital invested

Capital invested by funds: $39.8B → $39.3B (-$499M)

30% less call options, than puts

Call options by funds: $554M | Put options by funds: $785M

31% less funds holding in top 10

Funds holding in top 10: 139 (-4)

Holders
1,410
Holders Change
+3
Holders Change %
+0.21%
% of All Funds
18.56%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.12%
New
126
Increased
562
Reduced
504
Closed
106
Calls
$554M
Puts
$785M
Net Calls
-$232M
Net Calls Change
+$213M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.6B -$21.2M -274,356 -0.5%
Dodge & Cox
2
Dodge & Cox
California
$4.28B -$56.4M -731,296 -1%
BlackRock
3
BlackRock
New York
$3.82B +$42.9M +556,133 +1%
State Street
4
State Street
Massachusetts
$2.09B -$60.2M -780,385 -3%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$1.63B -$483M -6,260,847 -24%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$1.03B -$11.7M -151,033 -1%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$997M -$132M -1,710,260 -12%
Morgan Stanley
8
Morgan Stanley
New York
$914M -$40.9M -529,986 -4%
Norges Bank
9
Norges Bank
Norway
$756M +$1.25M +16,222 +0.2%
Pzena Investment Management
10
Pzena Investment Management
New York
$735M +$45.2M +585,671 +7%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$652M -$58.2M -753,757 -9%
Ameriprise
12
Ameriprise
Minnesota
$594M -$970K -12,566 -0.2%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$568M +$30.4M +393,380 +6%
Northern Trust
14
Northern Trust
Illinois
$546M -$24.6M -318,863 -4%
Invesco
15
Invesco
Georgia
$533M +$12.5M +162,041 +3%
ClearBridge Investments
16
ClearBridge Investments
New York
$474M +$9.87M +127,857 +2%
UBS AM
17
UBS AM
Illinois
$426M +$24.6M +319,134 +6%
Bank of America
18
Bank of America
North Carolina
$421M -$6.64M -86,045 -2%
Amundi
19
Amundi
France
$361M +$99.7M +1,292,107 +40%
Nordea Investment Management
20
Nordea Investment Management
Sweden
$355M +$6.22M +80,633 +2%
Diamond Hill Capital Management
21
Diamond Hill Capital Management
Ohio
$330M -$7.56M -97,967 -2%
Legal & General Group
22
Legal & General Group
United Kingdom
$317M -$5.99M -77,591 -2%
JP Morgan Chase
23
JP Morgan Chase
New York
$309M -$371K -4,805 -0.1%
Charles Schwab
24
Charles Schwab
California
$305M -$6M -77,775 -2%
N
25
Nuveen
North Carolina
$296M -$17M -220,015 -6%

MET Hedge Fund Activity: Q2 2025 in Review

1,410 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in MetLife (MET) for Q2 2025, worth a combined $39.3B — down 1.3% from $39.8B a quarter earlier.

Buyers outnumbered sellers: 126 funds opened new MET positions and 106 closed out — a net gain of 20 holders — while 562 added to existing stakes and 504 trimmed.

The largest buyer was Amundi, adding an estimated $99.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $483M.

  • 1,410 institutional investors held MetLife (MET) as of Q2 2025, up from 1,407 in Q1 2025.
  • Funds reported $39.3B of MetLife stock for Q2 2025, down 1.3% quarter-over-quarter.
  • 126 funds opened new MetLife positions in Q2 2025 and 106 closed out, a net change of +20 holders.
  • The largest MetLife buyer in Q2 2025 was Amundi, an estimated $99.7M added.
  • The largest MetLife seller in Q2 2025 was T. Rowe Price Associates, an estimated $483M sold.

Based on aggregated 13F filings for Q2 2025.